Screener
Hemab Therapeutics Holdings, Inc. COAG Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Hemab Therapeutics Holdings, Inc.’s reported figures.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s free cash flow?
- Hemab Therapeutics Holdings, Inc. (COAG) reported free cash flow of -$22.66M in Q2 2026.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude